- Home
- VTR vs ALC Comparison
VTR vs ALC Comparison
Compare VTR & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTR
- ALC
- Stock Information
- Founded
- VTR 1983
- ALC 1945
- Country
- VTR United States
- ALC Switzerland
- Employees
- VTR N/A
- ALC N/A
- Industry
- VTR Real Estate Investment Trusts
- ALC Ophthalmic Goods
- Sector
- VTR Real Estate
- ALC Health Care
- Exchange
- VTR Nasdaq
- ALC Nasdaq
- Market Cap
- VTR 35.2B
- ALC 40.2B
- IPO Year
- VTR 1998
- ALC N/A
- Fundamental
- Price
- VTR $76.04
- ALC $73.89
- Analyst Decision
- VTR Buy
- ALC Buy
- Analyst Count
- VTR 12
- ALC 11
- Target Price
- VTR $75.92
- ALC $91.41
- AVG Volume (30 Days)
- VTR 2.7M
- ALC 2.0M
- Earning Date
- VTR 10-29-2025
- ALC 11-11-2025
- Dividend Yield
- VTR 2.52%
- ALC 0.29%
- EPS Growth
- VTR N/A
- ALC N/A
- EPS
- VTR 0.53
- ALC 2.16
- Revenue
- VTR $5,544,046,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- VTR $16.61
- ALC $5.87
- Revenue Next Year
- VTR $9.31
- ALC $7.71
- P/E Ratio
- VTR $144.17
- ALC $33.88
- Revenue Growth
- VTR 16.38
- ALC 4.04
- 52 Week Low
- VTR $56.68
- ALC $71.55
- 52 Week High
- VTR $76.16
- ALC $99.20
- Technical
- Relative Strength Index (RSI)
- VTR 72.39
- ALC 42.21
- Support Level
- VTR $72.66
- ALC $72.42
- Resistance Level
- VTR $75.62
- ALC $75.28
- Average True Range (ATR)
- VTR 1.70
- ALC 1.12
- MACD
- VTR 0.46
- ALC 0.05
- Stochastic Oscillator
- VTR 98.91
- ALC 36.38
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.